Answers are grounded in this paper and cite their sources.
This editorial discusses the scientific rationale for using siRNA targeting angiotensinogen mRNA in the treatment of hypertension.
This editorial describes the science behind a study of a small interfering RNA, which targets angiotensinogen mRNA, to treat hypertension.
No takes yet. Share an insight, caveat, or question.
Rhian M. Touyz (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: